Certain medications, such as corticosteroids and infliximab (an anti-αTNF monoclonal antibody), are becoming increasingly important risk factors, especially in the developed world.
Visse lægemidler, såsom kortikosteroider og infliximab (et monoklonalt antistof mod TNF-α) udgør en stadig større risikofaktor især i i-landene.